Fig. S3.
Morphology of WM983-A (VGP) and WM1158 (RGP/VGP) melanoma cells treated with anle138b or anle138c. Phase-contrast images, captured at 10× magnification, showing the morphology of WM983-A (A) and WM1158 (B) melanoma cells that had received DMSO only or had been treated with a single dose (10 µM) of anle138b or anle138c for 36, 48, 75, or 96 h with replenishment of an equivalent dose of each compound or DMSO only at 48 h.